Patents by Inventor Jeanette Painstil

Jeanette Painstil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Papilloma Virus-Like Particles, Fusion Proteins as Well as Processes for Their Production
    Publication number: 20110015376
    Abstract: The invention relates to the recombinant production of proteins as well as VLPs which are suitable as a vaccine for therapeutic and prophylactic vaccination. The invention also relates to processes for the production and purification of recombinant papilloma virus proteins and fusion proteins.
    Type: Application
    Filed: August 25, 2008
    Publication date: January 20, 2011
    Applicant: LOYOLA UNIVERSITY OF CHICAGO
    Inventors: Lutz Gissmann, Jian Zhou, Martin Muller, Jeanette Painstil
  • Papilloma virus-like particles, fusion proteins as well as processes for their production
    Patent number: 7416732
    Abstract: The invention relates to the recombinant production of proteins as well as VLPs which are suitable as a vaccine for therapeutic and prophylactic vaccination. The invention also relates to processes for the production and purification of recombinant papilloma virus proteins and fusion proteins.
    Type: Grant
    Filed: February 21, 2006
    Date of Patent: August 26, 2008
    Assignee: Loyola University of Chicago
    Inventors: Lutz Gissmann, Jian Zhou, Martin Muller, Jeanette Painstil
  • Papilloma virus-like particles, fusion proteins as well as processes for their production
    Publication number: 20060153864
    Abstract: The invention relates to the recombinant production of proteins as well as VLPs which are suitable as a vaccine for therapeutic and prophylactic vaccination. The invention also relates to processes for the production and purification of recombinant papilloma virus proteins and fusion proteins.
    Type: Application
    Filed: February 21, 2006
    Publication date: July 13, 2006
    Inventors: Lutz Gissmann, Jian Zhou, Martin Muller, Jeanette Painstil
  • Papilloma virus-like particles, fusion proteins as well as processes for their production
    Publication number: 20040202679
    Abstract: The invention relates to the recombinant production of proteins as well as VLPs which are suitable as a vaccine for therapeutic and prophylactic vaccination. The invention also relates to processes for the production and purification of recombinant papilloma virus proteins and fusion proteins.
    Type: Application
    Filed: July 1, 2003
    Publication date: October 14, 2004
    Applicant: Loyola University of Chicago
    Inventors: Lutz Gissmann, Jian Zhou, Martin Muller, Jeanette Painstil
  • Papilloma virus-like particles, fusion proteins as well as processes for their production
    Patent number: 6599508
    Abstract: The invention relates to the recombinant production of proteins as well as VLPs which are suitable as a vaccine for therapeutic and prophylactic vaccination. The invention also relates to processes for the production and purification of recombinant papilloma virus proteins and fusion proteins.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: July 29, 2003
    Assignee: Loyola University of Chicago
    Inventors: Lutz Gissmann, Jian Zhou, Martin Muller, Jeanette Painstil
  • Carboxyl terminal of papillomavirus L1 region is not required for formation of virus-like particles
    Patent number: 6361778
    Abstract: Papillomavirus-like particles (VLPs) comprising truncated L1 proteins are provided wherein the L1 proteins have one or more carboxy terminal amino acid residues deleted.
    Type: Grant
    Filed: September 16, 1999
    Date of Patent: March 26, 2002
    Inventors: Lutz Gissmann, Jian Zhou, Martin Muller, Jeanette Painstil
  • Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles
    Patent number: 6066324
    Abstract: Recombinant papilloma virus-like particles result from the expression of viral structural protein L1 and/or L2 in which one or several sections of the L1 and/or L2 protein are deleted. The ability to form virus-like particles is at least the same as, preferably higher than, that of native reproduction and/or in vitro production processes.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: May 23, 2000
    Assignee: Loyola University of Chicago
    Inventors: Lutz Gissmann, Jian Zhou, Martin Muller, Jeanette Painstil